At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BBH VanEck Biotech ETF
Market Closed 07-17 16:00:00 EDT
204.78
-1.48
-0.72%
盘后204.23
-0.55-0.27%
17:00 EDT
High207.09Low204.23Vol2.92K
Open206.01D1 Closing206.25Amplitude1.39%
Mkt Cap398.60MTradable Cap398.60MTotal Shares1.95M
T/O600.29KT/O Rate0.15%Tradable Shares1.95M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors
Dow Jones  ·  07-18 04:35
Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors
Coca-cola, IBM Share Losses Contribute to Dow's Nearly 300-point Drop
Dow Jones  ·  07-18 02:05
Coca-cola, IBM Share Losses Contribute to Dow's Nearly 300-point Drop
Amgen Halts Bemarituzumab Gastric Cancer Trial, Shifting Oncology Expectations
TIPRANKS  ·  07-18 00:30
Amgen Halts Bemarituzumab Gastric Cancer Trial, Shifting Oncology Expectations
Gilead’s Zamzetoclax Trial Update: What a Terminated Phase 1 Means for GILD Investors
TIPRANKS  ·  07-18 00:30
Gilead’s Zamzetoclax Trial Update: What a Terminated Phase 1 Means for GILD Investors
NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-07-17
Reuters  ·  07-17 23:01
NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-07-17
Sino Biopharmaceutical Stock Slips 5.3% in Hong Kong
Dow Jones  ·  07-17 16:31
Sino Biopharmaceutical Stock Slips 5.3% in Hong Kong
Gilead Chief Comm & Corp Aff Officer Johanna Mercier Sells 3,000 Shares for $389,757.60
Reuters  ·  07-17 04:55
Gilead Chief Comm & Corp Aff Officer Johanna Mercier Sells 3,000 Shares for $389,757.60
Moderna Inc. Stock Sheds 7.5%, Underperforms Peers
Dow Jones  ·  07-17 04:32
Moderna Inc. Stock Sheds 7.5%, Underperforms Peers
Amgen Inc Stock (AMGN) Closed Up by 3.70% on Jul 16: Drivers Behind the Movement
TradingKey  ·  07-17 04:15
Amgen Inc Stock (AMGN) Closed Up by 3.70% on Jul 16: Drivers Behind the Movement
Gyre Therapeutics Adds CSO Yue Xiong, Max Kirkby, Claire Weston to Board Effective Aug. 1
Reuters  ·  07-17 04:07
Gyre Therapeutics Adds CSO Yue Xiong, Max Kirkby, Claire Weston to Board Effective Aug. 1
Vertex’s VX-581 Dose Escalation Trial: A Fresh Signal on Cystic Fibrosis Pipeline Strength
TIPRANKS  ·  07-17 00:31
Vertex’s VX-581 Dose Escalation Trial: A Fresh Signal on Cystic Fibrosis Pipeline Strength
Gilead Targets Long-Acting HIV Regimens With New Injectable Study
TIPRANKS  ·  07-17 00:30
Gilead Targets Long-Acting HIV Regimens With New Injectable Study
Amgen Advances Obesity Pipeline With Fresh Data on AMG 133 Injection Formats
TIPRANKS  ·  07-17 00:30
Amgen Advances Obesity Pipeline With Fresh Data on AMG 133 Injection Formats
Amgen’s Rocatinlimab Eczema Trial Termination Jolts Investor Expectations
TIPRANKS  ·  07-17 00:30
Amgen’s Rocatinlimab Eczema Trial Termination Jolts Investor Expectations
Kalshi to Allow Bets on Clinical Trials, FDA Decisions
Reuters  ·  07-16 23:58
Kalshi to Allow Bets on Clinical Trials, FDA Decisions
Merck Gets US FDA Nod for First-in-its-class Oral Cholesterol Drug
Reuters  ·  07-16 20:04
Merck Gets US FDA Nod for First-in-its-class Oral Cholesterol Drug
Analysts Have Conflicting Sentiments on These Healthcare Companies: Gilead Sciences (GILD) and Johnson & Johnson (JNJ)
TIPRANKS  ·  07-16 17:30
Analysts Have Conflicting Sentiments on These Healthcare Companies: Gilead Sciences (GILD) and Johnson & Johnson (JNJ)
Revolution Medicines Inc : JP Morgan Raises Target Price to $205 from $200
THOMSON REUTERS  ·  07-16 17:04
Revolution Medicines Inc : JP Morgan Raises Target Price to $205 from $200
Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  07-16 04:35
Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day
Gilead Bdrs in Brazil Undergo 6-for-1 Stock Split, Ratio Shifts to 1:12
Reuters  ·  07-16 04:19
Gilead Bdrs in Brazil Undergo 6-for-1 Stock Split, Ratio Shifts to 1:12

Introduction

Company Name.
VanEck Biotech ETF
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Issue price:
--